Peptimmune, a Cambridge, Mass.-based biotechnology company, completed a second close on its Series D venture backing, worth $8.9 million. The round was led by New
Peptimmune, a Cambridge, Mass.-based biotechnology company, completed a second close on its Series D venture backing, worth $8.9 million. The round was led by New
Copyright PEI Media
Not for publication, email or dissemination